Advertisement

Topics

PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

19:44 EST 13 Nov 2017 | News-Medical.net

Patients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer major adverse limb events, such as acute limb ischemia - the equivalent of a heart attack in the leg - that can lead to limb loss.

Original Article: PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

NEXT ARTICLE

More From BioPortfolio on "PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...